SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-017176
Filing Date
2022-11-09
Accepted
2022-11-09 16:24:41
Documents
62
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rzlt-20220930x10q.htm   iXBRL 10-Q 900324
2 EX-31.1 rzlt-20220930xex31d1.htm EX-31.1 15329
3 EX-32.1 rzlt-20220930xex32d1.htm EX-32.1 7372
  Complete submission text file 0001558370-22-017176.txt   4487193

Data Files

Seq Description Document Type Size
4 EX-101.SCH rzlt-20220930.xsd EX-101.SCH 46315
5 EX-101.CAL rzlt-20220930_cal.xml EX-101.CAL 34153
6 EX-101.DEF rzlt-20220930_def.xml EX-101.DEF 199035
7 EX-101.LAB rzlt-20220930_lab.xml EX-101.LAB 301765
8 EX-101.PRE rzlt-20220930_pre.xml EX-101.PRE 290770
56 EXTRACTED XBRL INSTANCE DOCUMENT rzlt-20220930x10q_htm.xml XML 622411
Mailing Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065
Business Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065 650-206-4507
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39683 | Film No.: 221373043
SIC: 2834 Pharmaceutical Preparations